To confirm RUNX2 overexpression in lung cancer, we performed qPCR analysis and immunofluorescence assays in the lung adenocarcinoma cell lines PC9 and A549 and in the tumor tissues obtained from 11 patients, 5 with primary lung cancer and 6 with secondary cancer with lung metastasis. Here, RUNX2 is linked to cancer.